Mitomycin C 0.02 and 0.002% efficacy in preventing haze after photorefractive keratectomy
1Instituto de Olhos de Belo Horizonte (IOBH), Universidade Federal de Minas Gerais (UFMG), Padre Rolim Street, 541, Belo Horizonte, MG, Brazil. leticiamariacoelho@gmail.com.
Purpose:
To compare MMC 0.002% efficacy in preventing haze after PRK in relation to MMC 0.02%.
Patients And Methods:
We conducted a prospective study with patients with myopia or myopic astigmatism undergoing PRK in the same conditions. After PRK, MMC was applied for 30 s in a concentration of 0.02% on the right eye (group 1) and 0.002% on the left eye (group 2). Age, gender, spherical equivalent and haze intensity (1, 3, 6 and 12 months postoperatively) were assessed. Haze was quantified at biomicroscopy (0-4 +). P < 0.05 was considered statistical significant.
Results:
We evaluated 130 patients, 77 women and 53 men, with a mean age of 30.2 ± 9 years. The spherical equivalent was - 3.66 D in the group 1 and - 3.77 D in the group 2. In the 1st month after PRK, incidence of haze was 13.9% eyes in group 1 and 14.6% in group 2. In the 3rd month, incidence of haze was 50.0% eyes in group 1 and 48.5% in group 2 which presented with 3 +/4 + traces of haze. In the 12th month, incidence of haze was 7.7% eyes in group 1 and 5.4% in group 2. There was no correlation between haze and age (p = 0.279/0.333), gender (p = 0.345/0.367) or spherical equivalent (p = 0.100/0.054) in groups 1 and 2, respectively. There was no difference in haze between groups 1 and 2 (p = 0.56).
Conclusion:
MMC 0.002% was effective in preventing haze after PRK. As MMC long-term safety has not been proved, we suggest its use in a lower concentration, in order to prevent potential complications.
Insights
Low-concentration mitomycin C (MMC) 0.002% effectively prevents haze after photorefractive keratectomy (PRK). This study suggests using lower MMC concentrations to minimize potential long-term complications.
Area of Science:
- Ophthalmology
- Corneal Surgery
- Pharmacology
Background:
- Post-photorefractive keratectomy (PRK) haze is a common complication.
- Mitomycin C (MMC) is used to inhibit fibroblast proliferation and prevent haze.
- Optimal MMC concentration for haze prevention requires further investigation.
Purpose of the Study:
- To compare the efficacy of mitomycin C (MMC) 0.002% versus 0.02% in preventing corneal haze after photorefractive keratectomy (PRK).
Main Methods:
- A prospective study involving 130 patients undergoing PRK for myopia or myopic astigmatism.
- MMC 0.02% applied to the right eye (group 1) and 0.002% to the left eye (group 2) for 30 seconds post-PRK.
- Haze intensity was quantified at 1, 3, 6, and 12 months postoperatively.
Main Results:
- No statistically significant difference in haze incidence or intensity was observed between the 0.02% and 0.002% MMC groups at any time point.
- Haze incidence was 7.7% in the 0.02% group and 5.4% in the 0.002% group at 12 months.
- No correlation was found between haze and patient age, gender, or spherical equivalent.
Conclusions:
- Mitomycin C (MMC) at a 0.002% concentration is effective in preventing haze after photorefractive keratectomy (PRK).
- Given the unproven long-term safety of higher MMC concentrations, lower concentrations are recommended to mitigate potential complications.
- Further research into the long-term safety profile of MMC in corneal surgery is warranted.
Related Concept Videos
Self-Efficacy
Cancer Prevention
Some...
Prevention of Further Absorption of Poison
Preventive Healthcare Services
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...


